SARS-CoV-2: the viral shedding vs infectivity dilemma

Field	Value	Language
dc.contributor.author	Widders, Arabella	en
dc.contributor.author	Broom, Alex	en
dc.contributor.author	Broom, Jennifer	en
dc.date.accessioned	2020-06-18
dc.date.available	2020-06-18
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/22558
dc.description.abstract	Viral shedding has been demonstrated up to 63 days after symptom onset. The distinction between viral shedding and infectivity is important for the development of quarantine guidelines and policy.There is an earlier peak in viral load in SARS-CoV-2 than seen in SARS. Quantitative viral loads are higher in the nose than the throat. It is likely that asymptomatic and presymptomatic transmission is occurring.	en
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	SARS-CoV-2: the viral shedding vs infectivity dilemma	en
dc.type	Article	en
dc.identifier.doi	10.1016/j.idh.2020.05.002
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.